|
|
||||||||
Published online before print April 13, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

* Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Avon, United Kingdom; and
Novartis Horsham Research Centre, West Sussex, United Kingdom
1Correspondence: Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Bath, Avon, UK BA2 7AY. E-mail: S.G.Ward{at}bath.ac.uk
Macrophage-derived chemokine [CC chemokine ligand 22 (CCL22)] and thymus- and activation-regulated chemokine (CCL17) mediate cellular effects, principally by binding to their receptor CC chemokine receptor 4 (CCR4) and together, constitute a multifunctional chemokine/receptor system with homeostatic and inflammatory roles within the body. This study demonstrates that CCL22 and CCL17 stimulate pertussis toxin-sensitive elevation of intracellular calcium in the CEM leukemic T cell line and human peripheral blood-derived T helper type 2 (Th2) cells. Inhibition of phospholipase C (PLC) resulted in the abrogation of chemokine-mediated calcium mobilization. Chemokine-stimulated calcium responses were also abrogated completely by the inhibition of inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] receptor-mediated calcium release. Chemotactic responses of CEM and human Th2 cells to CCL17 and CCL22 were similarly abrogated by inhibition of PLC and inhibition of novel, Ca2+-independent/diacylglycerol-dependent protein kinase C (PKC) isoforms. Inhibition of Ins(1,4,5)P3 receptor-mediated calcium release from intracellular stores had no effect on chemotactic responses to CCR4 ligands. Taken together, this study provides compelling evidence of an important role for PLC and diacylglycerol-dependent effector mechanisms (most likely involving novel PKC isoforms) in CCL17- and CCL22-stimulated, directional cell migration. In this regard, CCL22 stimulates phosphatidylinositol-3 kinase-independent phosphorylation of the novel
isoform of PKC at threonine 505, situated within its activation loopan event closely associated with increased catalytic activity.
Key Words: chemokines signaling chemotaxis PKC
This article has been cited by other articles:
![]() |
D. Galimberti, C. Fenoglio, C. Comi, D. Scalabrini, M. De Riz, M. Leone, E. Venturelli, F. Cortini, M. Piola, F. Monaco, et al. MDC/CCL22 intrathecal levels in patients with multiple sclerosis Multiple Sclerosis, May 1, 2008; 14(4): 547 - 549. [Abstract] [PDF] |
||||
![]() |
R. A. Lacalle, R. M. Peregil, J. P. Albar, E. Merino, C. Martinez-A, I. Merida, and S. Manes Type I phosphatidylinositol 4-phosphate 5-kinase controls neutrophil polarity and directional movement J. Cell Biol., December 31, 2007; 179(7): 1539 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Patrussi, C. Ulivieri, O. M. Lucherini, S. R. Paccani, A. Gamberucci, L. Lanfrancone, P. G. Pelicci, and C. T. Baldari p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells Blood, September 15, 2007; 110(6): 1730 - 1738. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |